Bioss In Vivo Biosimilar Antibodies

Wednesday, 08 October, 2025 | Supplied by: Sapphire Bioscience


Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are used to study how drugs work.

These alternatives to pharmaceutical-grade therapeutics can be used in a variety of research applications. Each antibody is specifically formulated for in vivo applications and undergoes rigorous validation regarding purity and quality.

Bioss offers flexible quantities, from milligrams to grams, with swift delivery. The company has a collection of 1000+ high-quality biosimilar antibodies for in vivo research, which are distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits

HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...

Amsbio validated cytokines for organoid culture

Amsbio has launched over a range of over 30 independently developed and manufactured organoid...

Dendritics monoclonal antibodies for dendritic cell research

Dendritics' mouse and rat antibodies are logically grouped into several product families: DC...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd